Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
2-Aminotetralones: Novel inhibitors of MurA and MurZDunsmore, Colin J. ; Miller, Keith ; Blake, Katy L. ; Patching, Simon G. ; Henderson, Peter J.F. ; Garnett, James A. ; Stubbings, William J. ; Phillips, Simon E.V. ; Palestrant, Deborah J. ; Angeles, Joseph De Los ; Leeds, Jennifer A. ; Chopra, Ian ; Fishwick, Colin W.G.Bioorganic & medicinal chemistry, 2008-03, Vol.18 (5), p.1730-1734 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
2-(Arylmethyl)-3-substituted quinuclidines as selective α7 nicotinic receptor ligandsMazurov, Anatoly ; Klucik, Jozef ; Miao, Lan ; Phillips, Teresa Y. ; Seamans, Angela ; Schmitt, Jeffrey D. ; Hauser, Terry A. ; Johnson, Raymond T. ; Miller, CraigBioorganic & medicinal chemistry letters, 2005-04, Vol.15 (8), p.2073-2077 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
5'-Alkyl-benzothiadiazides: A new subgroup of AMPA receptor modulators with improved affinityPHILLIPS, Dean ; SONNENBERG, Jennifer ; ARAI, Amy C ; VASWANI, Rishi ; KRUTZIK, Peter O ; KLEISLI, Thomas ; KESSLER, Markus ; GRANGER, Richard ; LYNCH, Gary ; CHAMBERLIN, A. RichardBioorganic & medicinal chemistry, 2002-05, Vol.10 (5), p.1229-1248 [Periódico revisado por pares]Oxford: Elsevier ScienceTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
5‐fluorouracil and methotrexate administered simultaneously as a continuous infusion. A phase I studyLokich, Jacob J. ; Phillips, Donald ; Green, Robert ; Paul, Steven ; Sonneborn, Henry ; Zipoli, Thomas E. ; Curt, GregoryCancer, 1985-11, Vol.56 (10), p.2395-2398 [Periódico revisado por pares]New York: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Abstracts of the 20th International Isotope Society (UK group) Symposium: Synthesis & Applications of Labelled Compounds 2011Aigbirhio, F. ; Appleyard, M. V. C. L. ; Arrowsmith, R. L. ; Baldwin, S. A. ; Bayrakdarian, M. ; Botting, N. P. ; Cantin, L. D. ; Carbery, D. R. ; Carroll, M. A. ; Dixon, L. I. ; Dorff, P. N. ; Ellames, G. ; Elmore, C. S. ; Fishwick, C. W. G. ; Foot, O. ; Geach, N. J. ; Gowdy, J. ; Grainger, R. S. ; Gregson, T. ; Harker, W. R. R. ; Henderson, P. J. F. ; Heys, J. R. ; Homans, S. W. ; Hu, Z. ; Jackson, S. ; Johnston, J. ; Johnson, P. ; Kalverda, A. ; Kay, C. ; Kitson, S. L. ; Lanoue, B. ; Levitt, M. H. ; Li, Y. ; Lockley, W. J. S. ; Luo, X ; Ma, P. ; Middleton, D. A. ; Newsome, J. ; Pandya, B. ; Pascu, S. I. ; Patching, S. G. ; Phillips-Jones, M. K. ; Powell, M. E. ; Riss, P. ; Simmons, J. ; Simpson, T. M. ; Smith, A. D. ; Thompson, A. M. ; Trembleau, L. ; Turtle, R. ; Watters, K. W. ; Zhang, Q.Journal of labelled compounds & radiopharmaceuticals, 2012-03, Vol.55 (3), p.125-134 [Periódico revisado por pares]Chichester, UK: John Wiley & Sons, LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Accumulation of PEG-liposomes in the Inflamed Colon of Rats: Potential for Therapeutic and Diagnostic Targeting of Inflammatory Bowel DiseasesAwasthi, V.D. ; Goins, B. ; Klipper, R. ; Phillips, W.T.Journal of drug targeting, 2002-08, Vol.10 (5), p.419-427 [Periódico revisado por pares]Abington: Informa UK LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Activation of tamoxifen and its metabolite α-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytesPhillips, David H. ; Carmichael, Paul L. ; Hewer, Alan ; Cole, Kathleen J. ; Hardcastle, Ian R. ; Poon, Grace K. ; Keogh, Adrian ; Strain, Alastair J.Carcinogenesis (New York), 1996-01, Vol.17 (1), p.89-94 [Periódico revisado por pares]Oxford: Oxford University PressTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Activity and DNA binding of new organoamidoplatinum (II) complexesTALARICO, T ; PHILLIPS, D. R ; DEACON, G. B ; RAINONE, S ; WEBSTER, L. KInvestigational new drugs, 1999-02, Vol.17 (1), p.1-15 [Periódico revisado por pares]Dordrecht: KluwerTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trialvan der Heijde, D ; Schiff, M H ; Sieper, J ; Kivitz, A J ; Wong, R L ; Kupper, H ; Dijkmans, B A C ; Mease, P J ; Davis, J CAnnals of the rheumatic diseases, 2009-06, Vol.68 (6), p.922-929 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Adalimumab Reduces Pain, Fatigue, and Stiffness in Patients with Ankylosing Spondylitis: Results from the Adalimumab Trial Evaluating Long-Term Safety and Efficacy for Ankylosing Spondylitis (ATLAS)REVICKI, Dennis A ; LUO, Michelle P ; WORDSWORTH, Paul ; WONG, Robert L ; CHEN, Naijun ; DAVIS, John CJournal of rheumatology, 2008-07, Vol.35 (7), p.1346-1353 [Periódico revisado por pares]Toronto, ON: The Journal of RheumatologyTexto completo disponível |